Cat.#: ASSD-138
| Description | A3AR covalent antagonist.Binds irreversibly. Apparent pKi values at A3ARs are 6.9 and 8.0 (after 4h), where a Ki shift indicates a covalent mode of action. |
| Size | 50 μg |
| Chemical Name | 4-[3-(8-Methoxy-2,4-dioxo-3-propylpurino[7,8-a]pyridin-1-yl)propylcarbamoyl]benzenesulfonyl fluoride |
| Molecule Weight | 517.5 |
| Molecular formula | C23H24FN5O6S |
| PubChem identifier | 155513958 |
| Purity | >95% |
| Solubility | Soluble in DMSO |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-176 | Rhodamine B isothiocyanate (AC176) | 100 mg, 500 mg | inquiry |
| ASSD-165 | FLUO 3-AM (AC165) | 1 mg | inquiry |
| ASSD-208 | NBD-X, succinimidyl ester (AC208) | 100 mg | inquiry |
| ASSD-172 | Ionomycin free acid (AC172) | 1mg, 5mg | inquiry |
| ASSD-217 | t-Boc-MTSEA-Fluorescein (AC217) | 10 mg | inquiry |
| ASSD-194 | 7-(Diethylamino)coumarin-3-carboxylic acid (AC194) | 100 mg | inquiry |
| ASSD-199 | 4,7-Dioxaoctylenediamine N-[(Cyanine 3) Monofunctional Hexanoic Acid]-N′-[2-fluoro-4′-phosphophenylacetic Acid] Diamide (AC199) | 500 μg | inquiry |
| ASSD-108 | Neutral Red Solution (0.33%) (AC108) | 50 mL, 100 mL | inquiry |
| ASSD-111 | Propidium Iodide (AC111) | 10 mg, 50 mg | inquiry |
| ASSD-143 | Fluorescently labeled Muscimol TMR-X conjugate (AC143) | 1mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.